Website of DuPont Intellectual Assets Business DuPont The Miracles of Science
Search Technologies Perform the Search
Contact DuPont Technology Bank Frequently Asked Questions
DuPont Technology Bank Home Search Technologies Featured Technologies What We License Technology of the Week at yet2.com Science
DuPont Technology
WorldwideHome

DuPont Technology 
Overview
Novelty
Development
Intellectual Property
Provider Demographics
Technical Details
Licensing

 Actions
Request an Introduction
Ask the Owner a Question
Print this DuPont Technology


Testing Methods Using OncoMouse® Transgenic Models of Cancer

OncoMouse® models of cancer enhance research productivity by yielding direct results through in vivo study of tumorigenesis in the relevant physiological context (breast cancer in breast epithelium) in contrast to xenografts or implants. Researchers can assess materials for (1) carcinogenicity and (2) the pharmacological effect of anticancer and chemopreventive agents. OncoMouse® cancer models follow a normal progression of disease in animals that have an intact immune system.

Benefits Summary

The OncoMouse® transgenic animals have been modified in a manner that gives them a propensity for neoplasm development. Such animals can be used in experiments that test suspected carcinogens or screen anticancer and chemopreventive agents. more

Development Summary

Important Notice to OncoMouse® Users: Modification of Terms of Non-Commercial Research Licenses: The OncoMouse® technology is in wide commercial use. Free academic non-commercial research licenses have been executed with nearly 350 nonprofit universities and research institutions worldwide. Restrictions in these non-commercial research licenses that may have existed in the past limiting the ability for these nonprofit universities and research institutions to form academic/industry partnerships in the field of cancer research are waived by DuPont, and future non-commercial OncoMouse® research license agreements with nonprofit universities and research institutions will be issued without such restrictions. Consistent with this waiver and the terms of future agreements, DuPont agrees that it will not enforce any limitations in material transfer agreements between the Public Health Service of the U.S. Department of Health and Human Services and nonprofit universities or research institutions that would restrict formation of academic/industry partnerships in the field of cancer research. more

IP Summary

Patent information has not been disclosed.


FAQs Site Map Terms of Use Privacy Statement Contact Us Log In/Register

Bottom Toolbar
Copyright © 2008 DuPont. All rights reserved. The DuPont Oval Logo, DuPont™, The miracles of science™ and all products denoted with ® or ™ are registered trademarks or trademarks of E. I. du Pont de Nemours and Company or its affiliates.

DuPont TechnologyBank™ web site powered by
Visit the yet2.com Technology Marketplace